<DOC>
	<DOCNO>NCT01671735</DOCNO>
	<brief_summary>This study collect baseline survey data NCP fund VA Diabetes Prevention Program ( VA DPP ) clinical demonstration program three medical center VA DPP participant VA DPP-eligible VA MOVE ! participant identify baseline participant demographic characteristic ; attitude beliefs diet , exercise weight loss , psychosocial construct social support ; self-regulation skill predict 6-month weight loss program attendance . The data collect contribute knowledge pre-diabetic Veterans ' attitude beliefs diet , exercise weight loss , understand different program may impact weight loss , evidence-based target future clinical implementation project . It also provide baseline quality life data use future cost-effectiveness analysis .</brief_summary>
	<brief_title>VA Diabetes Prevention : Epidemiology Pre-Diabetes Implementation Pilot</brief_title>
	<detailed_description>Background : Type 2 diabetes preventable disease . Multiple large scale randomize controlled trial show people impair glucose tolerance , Type 2 diabetes prevent prevention lifestyle intervention emphasize diet , exercise weight loss . The Diabetes Prevention Program ( DPP ) show lifestyle intervention reduce incidence type 2 diabetes 58 % high risk group . Little known incidence pre-diabetes VA routine screen pre-diabetes establish practice VA. With exception , lifestyle modification intervention target individual pre-diabetes follow Diabetes Prevention Program curriculum available Veterans VA . In order address gap evidence base clinical service , National Center Health Promotion Disease Prevention ( NCP ) fund VA Diabetes Prevention Program Demonstration Project ( VA DPP ) 3 VA Medical Centers ( Baltimore , Minneapolis , Greater Los Angeles ) . NCP request assistance conduct extensive implementation focus evaluation VA DPP . Methods Baseline survey data collect 720 Veterans eligible VA DPP ( 360 VA DPP group , 360 VA MOVE ! ) 3 Medical Centers across country . All participant refer VA MOVE ! program evaluate VA DPP eligibility schedule VA MOVE ! orientation meeting . At face-to-face orientation meeting , VA DPP-eligible Veterans invite complete baseline survey complete informed consent process sign write informed consent document . Consented Veterans provide paper copy survey , stamp return envelope address Ann Arbor VA coordinate center incentive gift card voucher . Instructions survey include URL link online survey use Veterans prefer answer survey online oppose take paper survey . The survey include unique participant code use match survey data clinical administrative data participant . The participant code also use access online survey . There personal identifier survey . Objectives 1 . To identify baseline participant demographic characteristic : attitude beliefs diet , exercise weight loss : psychosocial construct social support ; self-regulation skill predict 6-month weight loss program attendance . 2 . To collect baseline survey data hypothesize modifiable mediator program impact weight loss include outcome expectation , self-regulation , skill mastery , willingness self-monitor , self-efficacy use subsequent analyse 6- 12-month survey data collect quality life data use future cost-effectiveness study .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Overweight obese Veterans qualify VA MOVE ! also prediabetes CDC NDPRP criterion ( fast glucose 100 125 mg/dl Hgb A1C 5.7 6.4 ) live within one hour one three VAMCs ( Baltimore , Minneapolis Greater Los Angeles ) eligible VA DPP program Veterans assign VA DPP program Veterans screen VA DPP program eligible class fill assign VA MOVE ! ask consent complete survey questionnaire time enrollment They also ask consent access link program data ( weight , BMI , visit attendance ) survey data Patients A1C 6.56.9 % although consider prediabetic VA criterion , exclude , consider diabetic base upon ADA NDPRP criterion VA DPP clinical program Similarly , patient treat metformin exclude , avoid confound factor analysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>prevention</keyword>
	<keyword>diabetes</keyword>
</DOC>